RNS Number : 6247R
Legal & General UCITS ETF PLC
30 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
30/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
137286308.23 |
11.667 |
| L&G UK Equity UCITS ETF |
30/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10962694.98 |
9.136 |
| L&G Global Equity UCITS ETF |
30/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32552078.72 |
11.225 |
| L&G Japan Equity UCITS ETF |
30/06/2020 |
IE00BFXR5T61 |
11085000 |
USD |
115428080.60 |
10.413 |
| L&G Europe ex UK Equity UCITS ETF |
30/06/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
99876259.00 |
10.669 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
30/06/2020 |
IE00BFXR5W90 |
4605639 |
USD |
47377213.70 |
10.287 |
| L&G Clean Water UCITS ETF |
30/06/2020 |
IE00BK5BC891 |
1500000 |
USD |
15520612.99 |
10.347 |
| L&G Artificial Intelligence UCITS ETF |
30/06/2020 |
IE00BK5BCD43 |
6496000 |
USD |
82834267.18 |
12.752 |
| L&G Healthcare Innovation UCITS ETF |
30/06/2020 |
IE00BK5BC677 |
2650000 |
USD |
33256148.03 |
12.549 |
| L&G Pharma Breakthrough UCITS ETF |
30/06/2020 |
IE00BF0H7608 |
2150000 |
USD |
25643912.10 |
11.927 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
30/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
92898894.05 |
10.098 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
30/06/2020 |
IE00BKLWY790 |
57400000 |
USD |
602438806.66 |
10.495 |
| L&G Battery Value-Chain UCITS ETF |
30/06/2020 |
IE00BF0M2Z96 |
12100000 |
USD |
110806570.33 |
9.158 |
| L&G Ecommerce Logistics UCITS ETF |
30/06/2020 |
IE00BF0M6N54 |
5550000 |
USD |
58987800.67 |
10.628 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
30/06/2020 |
IE00BMW3QX54 |
47430616 |
USD |
816606434.94 |
17.217 |
| L&G Cyber Security UCITS ETF |
30/06/2020 |
IE00BYPLS672 |
81536776 |
USD |
1547753663.06 |
18.982 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVDZGFVZGMGGZZ
